BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26346272)

  • 21. Tumor-infiltrating CD4
    Franzoni MS; Brandi A; de Oliveira Matos Prado JK; Elias F; Dalmolin F; de Faria Lainetti P; Prado MCM; Leis-Filho AF; Fonseca-Alves CE
    Res Vet Sci; 2019 Oct; 126():29-36. PubMed ID: 31425936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of angiogenesis in canine mammary tumors by quantitative platelet endothelial cell adhesion molecule immunohistochemistry.
    Restucci B; De Vico G; Maiolino P
    Vet Pathol; 2000 Jul; 37(4):297-301. PubMed ID: 10896390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
    Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
    Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of vascular endothelial growth factor gene and protein expression in canine metastatic mammary carcinomas.
    Raposo-Ferreira TM; Salvador RC; Terra EM; Ferreira JH; Vechetti-Junior IJ; Tinucci-Costa M; Rogatto SR; Laufer-Amorim R
    Microsc Res Tech; 2016 Nov; 79(11):1097-1104. PubMed ID: 27543935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor.
    Moschetta MG; Leonel C; Maschio-Signorini LB; Borin TF; Gelaleti GB; Jardim-Perassi BV; Ferreira LC; Sonehara NM; Carvalho LGS; Hellmén E; de Campos Zuccari DAP
    Anticancer Agents Med Chem; 2019; 19(5):655-666. PubMed ID: 30569877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor Tyrosine Kinase Expression Profiles in Canine Cutaneous and Subcutaneous Mast Cell Tumors.
    Thompson JJ; Morrison JA; Pearl DL; Boston SE; Wood GA; Foster RA; Coomber BL
    Vet Pathol; 2016 May; 53(3):545-58. PubMed ID: 26459517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
    Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
    Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
    Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
    Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Nuti M; Taube ET; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
    Br J Cancer; 2018 Aug; 119(3):330-338. PubMed ID: 29955134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppression in Dogs During Mammary Cancer Development.
    Mucha J; Rybicka A; Dolka I; Szymańska J; Manuali E; Parzeniecka-Jaworska M; Kluciński W; Król M
    Vet Pathol; 2016 Nov; 53(6):1147-1153. PubMed ID: 27106740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intratumoral lymphocyte density on the disease-free survival and overall survival in malignant epithelial tumors of the ovary.
    Doğan Y; Erdoğan G; Peştereli HE; Tirak B; Karaveli S
    Eur J Gynaecol Oncol; 2009; 30(5):523-6. PubMed ID: 19899407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
    Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
    J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.
    Milosavljevic MZ; Jovanovic IP; Pejnovic NN; Mitrovic SL; Arsenijevic NN; Simovic Markovic BJ; Lukic ML
    Oncotarget; 2016 Apr; 7(14):18106-15. PubMed ID: 26919112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of vascular endothelial growth factor receptor Flk-1 in canine mammary tumours.
    Restucci B; Borzacchiello G; Maiolino P; Martano M; Paciello O; Papparella S
    J Comp Pathol; 2004; 130(2-3):99-104. PubMed ID: 15003465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-dimensional contrast-enhanced sonography in the assessment of breast tumor angiogenesis: correlation with microvessel density and vascular endothelial growth factor expression.
    Chen M; Wang WP; Jia WR; Tang L; Wang Y; Zhan WW; Fei XC
    J Ultrasound Med; 2014 May; 33(5):835-46. PubMed ID: 24764339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Kit expression, angiogenesis, and grading in canine mast cell tumour: a unique model to study c-Kit driven human malignancies.
    Patruno R; Marech I; Zizzo N; Ammendola M; Nardulli P; Gadaleta C; Introna M; Capriuolo G; Rubini RA; Ribatti D; Gadaleta CD; Ranieri G
    Biomed Res Int; 2014; 2014():730246. PubMed ID: 24900982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
    Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
    Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical determination of HER-2/neu, c-Kit (CD117), and vascular endothelial growth factor (VEGF) overexpression in malignant melanoma.
    Potti A; Moazzam N; Langness E; Sholes K; Tendulkar K; Koch M; Kargas S
    J Cancer Res Clin Oncol; 2004 Feb; 130(2):80-6. PubMed ID: 14634801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.
    Chang Y; Niu W; Lian PL; Wang XQ; Meng ZX; Liu Y; Zhao R
    World J Gastroenterol; 2016 Jun; 22(23):5422-9. PubMed ID: 27340359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias.
    Gelaleti GB; Jardim BV; Leonel C; Moschetta MG; Zuccari DA
    Vet Immunol Immunopathol; 2012 Apr; 146(2):106-12. PubMed ID: 22405680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.